Welcome to the Podiatry Arena forums

You are currently viewing our podiatry forum as a guest which gives you limited access to view all podiatry discussions and access our other features. By joining our free global community of Podiatrists and other interested foot health care professionals you will have access to post podiatry topics (answer and ask questions), communicate privately with other members, upload content, view attachments, receive a weekly email update of new discussions, access other special features. Registered users do not get displayed the advertisements in posted messages. Registration is fast, simple and absolutely free so please, join our global Podiatry community today!

  1. Everything that you are ever going to want to know about running shoes: Running Shoes Boot Camp Online, for taking it to the next level? See here for more.
    Dismiss Notice
  2. Have you considered the Critical Thinking and Skeptical Boot Camp, for taking it to the next level? See here for more.
    Dismiss Notice
  3. Have you considered the Clinical Biomechanics Boot Camp Online, for taking it to the next level? See here for more.
    Dismiss Notice
Dismiss Notice
Have you considered the Clinical Biomechanics Boot Camp Online, for taking it to the next level? See here for more.
Dismiss Notice
Have you liked us on Facebook to get our updates? Please do. Click here for our Facebook page.
Dismiss Notice
Do you get the weekly newsletter that Podiatry Arena sends out to update everybody? If not, click here to organise this.

dermaPACE for diabetic foot ulcers

Discussion in 'Diabetic Foot & Wound Management' started by NewsBot, Sep 6, 2007.

  1. NewsBot

    NewsBot The Admin that posts the news.

    Articles:
    1

    Members do not see these Ads. Sign Up.
    Press Release:
    SANUWAVE, Inc. announces conditional approval from the FDA of its
    Investigational Device Exemption (IDE) application to begin a U.S. clinical trial of
    the dermaPACE Device for the treatment of diabetic foot ulcers

     
  2. NewsBot

    NewsBot The Admin that posts the news.

    Articles:
    1
    Press Release:
    The Microcirculatory Effects of SANUWAVE’s PACE Technology Explained in Presentation by Joanna Cwykiel of Cleveland Clinic
     
  3. NewsBot

    NewsBot The Admin that posts the news.

    Articles:
    1
    Press Release:
    DERMAPACE PIVOTAL PHASE III CLINICAL TRIAL RESULTS FOR DIABETIC FOOT ULCER TREATMENT TO BE PRESENTED AT THE SYMPOSIUM ON ADVANCED WOUND CARE (SAWC) SPRING 2011
     
  4. NewsBot

    NewsBot The Admin that posts the news.

    Articles:
    1
    Press Release:
    Sanuwave dealt setback for medical device sales of new diabetic foot ulcer treatment
    Dec 27, 2011
     
  5. NewsBot

    NewsBot The Admin that posts the news.

    Articles:
    1
    Press Release:
    SANUWAVE Issued U.S. Patent for the Application of Acoustic Shock Waves Utilizing Its PACE Devices
     
  6. NewsBot

    NewsBot The Admin that posts the news.

    Articles:
    1
    Press Release:
    SANUWAVE Receives Conditional Approval from the FDA on Clinical Trial Plan for dermaPACE

     
  7. NewsBot

    NewsBot The Admin that posts the news.

    Articles:
    1
    This Clinical Trial was just registered:
    A Comparison of the dermaPACE® (Pulsed Acoustic Cellular Expression) Device in Conjunction With Standard of Care Versus Standard of Care Alone in the Treatment of Diabetic Foot Ulcers

     
  8. Admin2

    Admin2 Administrator Staff Member

  9. NewsBot

    NewsBot The Admin that posts the news.

    Articles:
    1
    Press Release:
    SANUWAVE Announces 24-Week Data From Its Pivotal Trials Investigating the Use of dermaPACE for the Treatment of Diabetic Foot Ulcers
     
  10. NewsBot

    NewsBot The Admin that posts the news.

    Articles:
    1
Loading...

Share This Page